Zyanya Espinosa

Dr. Zyanya Espinosa

Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2020 in Cells
Verified
Journal Article
Open access
PDF file
Zyanya EspinosaZyanya Espinosa
Zyanya Espinosa
Deisy Segura-VillalobosDeisy Segura-Villalobos
Deisy Segura-Villalobos
IRItzel G. Ramírez-Moreno
Itzel G. Ramírez-Moreno
MRMarian Jesabel Pérez Rodríguez
Marian Jesabel Pérez Rodríguez
MLMonica Lamas
Monica Lamas
CGClaudia González-Espinosa
Claudia González-Espinosa
Mast cells (MCs) constitute an essential cell lineage that participates in innate and adaptive immune responses and whose phenotype and function are influenced by tissue-specific conditions. Their mechanisms of activation in type I hypersensitivity reactions have been the subject of multiple studies, but the signaling pathways behind their activation by innate immunity stimuli are not so well described. Here, we review the recent evidence regarding the main molecular elements and signaling pathways connecting the innate immune receptors and hypoxic microenvironment to cytokine synthesis and the secretion of soluble or exosome-contained mediators in this cell type. When known, the positive and negative control mechanisms of those pathways are presented, together with their possible implications for the understanding of mast cell-driven chronic inflammation. Finally, we discuss the relevance of the knowledge about signaling in this cell type in the recognition of MCs as central elements on innate immunity, whose remarkable plasticity converts them in sensors of micro-environmental discontinuities and controllers of tissue homeostasis.

1 January 2016
Verified
Book Chapter
Closed access
GVGenaro Vázquez-Victorio
Genaro Vázquez-Victorio
CGClaudia González-Espinosa
Claudia González-Espinosa
Zyanya EspinosaZyanya Espinosa
Zyanya Espinosa
MMMarina Macías-Silva
Marina Macías-Silva

15 April 2019 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
Zyanya EspinosaZyanya Espinosa
Zyanya Espinosa
AIAlfredo Ibarra-Sánchez
Alfredo Ibarra-Sánchez
SVShamila Vibhushan
Shamila Vibhushan
MBManuela Bratti
Manuela Bratti
NCNicolas Charles
Nicolas Charles
CGClaudia González-Espinosa
Claudia González-Espinosa
Mast cells (MCs) contribute to the control of local inflammatory reactions and become hyporesponsive after prolonged TLR4 activation by bacterial LPS. The molecular mechanisms involved in endotoxin tolerance (ET) induction in MCs are not fully understood. In this study, we demonstrate that the endocannabinoid 2-arachidonoylglycerol (2-AG) and its receptor, cannabinoid receptor 2 (CB2), play a role in the establishment of ET in bone marrow–derived MCs from C57BL/6J mice. We found that CB2 antagonism prevented the development of ET and that bone marrow–derived MCs produce 2-AG in a TLR4-dependent fashion. Exogenous 2-AG induced ET similarly to LPS, blocking the phosphorylation of IKK and the p65 subunit of NF-κB and inducing the synthesis of molecular markers of ET. LPS caused CB2 receptor trafficking in Rab11-, Rab7-, and Lamp2-positive vesicles, indicating recycling and degradation of the receptor. 2-AG also prevented LPS-induced TNF secretion in vivo, in a MC-dependent model of endotoxemia, demonstrating that TLR4 engagement leads to 2-AG secretion, which contributes to the negative control of MCs activation. Our study uncovers a functional role for the endocannabinoid system in the inhibition of MC-dependent innate immune responses in vivo.

27 March 2022 in Addiction Biology
Verified
Journal Article
Closed access
ARAna K. Ruiz‐Quiñonez
Ana K. Ruiz‐Quiñonez
Zyanya EspinosaZyanya Espinosa
Zyanya Espinosa
CCCésar J. Carranza‐Aguilar
César J. Carranza‐Aguilar
TBThom Browne
Thom Browne
SCSilvia Lorenia Cruz
Silvia Lorenia Cruz

15 April 2012
Verified
Conference Paper
Closed access
HCHarsharon Chopra
Harsharon Chopra
Zyanya EspinosaZyanya Espinosa
Zyanya Espinosa
ACAnne E. Cress
Anne E. Cress
ISIsis C. Sroka
Isis C. Sroka
Tumor cell migration and invasion of nerves, a process known as perineural nerve invasion (PNI), is a major metastatic route for neurotropic cancers including prostate and pancreatic cancer. The laminin family of extracellular matrix glycoproteins derived from myelinating Schwann cells coat nerve axons and play a prominent role in the development and maintenance of the peripheral nervous system. Tumor cells undergoing PNI utilize the laminin rich nerves as they migrate and invade during metastasis. Evidence has shown that the A6B1 laminin receptor promotes tumor cell migration and invasion following cleavage of the receptor to form the variant A6pB1 by the serine protease urokinase plasminogen activator (uPA). Here we demonstrate Schwann cell regulation of A6pB1 formation on prostate and pancreatic tumor cell lines. Conditioned medium from the S16 and S16Y cell lines, which are immortalized Schwann cells of the myelinating and non-myelinating phenotype, respectively was provided to the prostate and pancreatic tumor cell lines. It was observed that S16Y conditioned medium inhibited A6 conversion to A6p while the myelinating S16 cells increased cleavage of the receptor in DU-145, CF-PAC1 and PC-3 cancer cells. This effect was reversible as replenishing standard media conditions following a 24 hour treatment with S16 or S16Y media brought integrin cleavage levels back to steady state levels by 24 hours. Further, conditioned medium from S16 cells significantly increased pancreatic tumor cell invasion while S16Y conditioned medium decreased invasion in a modified Boyden chamber Matrigel assay. The increased invasion mediated by myelinating Schwann cells was dependent on A6 since a function blocking antibody targeting A6 inhibited invasion. Taken together these results suggest that myelinating Schwann cells (S16Y) in the pancreatic and prostatic nerve environment promote A6B1 and A6pB1 receptor dependent tumor cell invasion during PNI. (Supported in part by NIH CA23074 and CA159406 and HHMI Grant 52005889) Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 502. doi:1538-7445.AM2012-502

Verified
Journal Article
Open access
PDF file
Zyanya EspinosaZyanya Espinosa
Zyanya Espinosa
J. Omar Muñoz-BelloJ. Omar Muñoz-Bello
J. Omar Muñoz-Bello
CGClaudia González-Espinosa
Claudia González-Espinosa
Alfredo Ibarra-SánchezAlfredo Ibarra-Sánchez
Alfredo Ibarra-Sánchez
MLMarcela Lizano
Marcela Lizano
Human Papillomavirus (HPV)-related cancers constitute a major global health problem, accounting for 4.5% of all human cancers. Studying the composition of the tumor microenvironment (TME) of HPV-related cancers may help develop therapeutic strategies or identify prognostic biomarkers with potential clinical significance. Among all the components of TME, mast cells (MCs) appear to be particularly relevant in HPV-related tumors. MCs are myeloid-derived immune cells that release a wide range of inflammatory mediators. It is now recognized that these immune cells are important players within the TME, where they can exert both anti- and pro-tumor activities depending on the type of MC-derived inflammatory mediators released. MCs may play an important role in the processes associated with cell transformation, development, and the progression of HPV-associated tumors; however, their specific functions in these neoplasms are not yet fully understood. This review addresses the current state of knowledge on MCs and their contribution to the molecular biology of HPV-related cancers. In addition, it highlights MCs’ roles in the pro- or anti-tumor paradigm and discusses their emerging potential as therapeutic targets or prognostic biomarkers.